Venner Shipley welcomes Brookes IP Read more
  • Great Britain
  • Germany
  • France
  • China
  • Souht Korea

Matthew Handley

MBiochem PhD EPA CPA

Partner, Patent Attorney

Partner, Patentanwalt

Associé, Patent Attorney

合伙人, 专利代理人

パートナー, 弁理士

파트너, 변리사

  • English (en)
  • 中文 (zh)

Profile

Matt is a UK and European patent attorney and has experience in drafting and prosecuting UK, European, and International patent applications, providing freedom-to-operate opinions, and advising clients on patent infringement and validity. Matt handles a wide range of subject matter in the fields of: biology, including new strains of microorganisms, medicinal compositions, and veterinary medicine; immunology, including vaccines, adoptive cell transfer, and tumour immunotherapies; molecular medicine, including stem cell therapies, chimeric antigen receptors, and precision medicine; and biochemistry, including gene editing, protein engineering, and antibody technologies.

Education

Matt graduated from the University of Oxford with a first class master’s degree in Molecular and Cellular Biochemistry, specialising in immunology. During his PhD at University College, London, he investigated the activation of dendritic cells and macrophages, and in particular, the intracellular signalling pathways regulating the activation, morphology, and survival of these cells. During this time, Matt developed a novel antibody-based assay for analysing and quantifying endocytic and phagocytic activity. Matt subsequently worked as a postdoctoral scientist in the Immunology Division of the National Institute for Medical Research, investigating the activation of macrophages using cellular, molecular biological, and transgenic technologies. During his post-doc, Matt also developed a novel antibody-based approach for measuring the activity of the Nf-kappaB pathway.

Awards and Recognition

  • Managing Intellectual Property, IP Stars (Notable Practitioner) – 2021

简介

马修∙汉德利于2007年加入文诺∙希普利,具有英国及欧洲专利律师资格。马特在起草和起诉英国、欧洲和国际专利申请方面拥有丰富的经验,提供了可实施性检索意见,并就客户的专利侵权和有效性提供建议。

马修在以下领域都有涉猎:生物学,包括微生物的新菌株、药物组合物和兽药;免疫学,包括疫苗、过继性细胞转移和肿瘤免疫疗法;分子医学,包括干细胞疗法,嵌合抗原受体和精密药物;和生物化学,包括基因编辑,蛋白质工程和抗体技术。

教育背景

马特毕业于牛津大学,获得分子和细胞生物化学一等硕士学位,专攻免疫学。在伦敦大学学院博士期间,他调查了树突状细胞和巨噬细胞的活化,特别是调节这些细胞活化,形态和存活的细胞内信号传导途径。在此期间,马修开发了一种基于抗体的新型分析方法,用于分析和定量内吞和吞噬活性。马修随后在国家医学研究所免疫学部继续他的博士后科研工作,利用细胞,分子生物学和转基因技术研究巨噬细胞的活化。在他的博士后期间,马修还开发了一种新的基于抗体的方法来测量Nf-kappaB途径的活性。

  • An antidote to antibody patent confusion in Europe

  • G3/19: EBA finds plants produced by essentially biological processes are not patentable

  • G3/19: EBA finds plants produced by essentially biological processes are not patentable

  • CRISPR patent appeal dismissed

  • President’s Referral to Enlarged Board of Appeal – Patentability of Plants and Plant Products

  • EPO Board of Appeal Resists EU Intervention on Patentability of Plants and Plant Products

  • European Patent Office News

  • CRISPR – testing the fundamentals of patent law

  • Inside IP Spring Summer 2018

  • EPO changes approach to the patentability of products of essentially biological processes

  • The future of medical treatment – precision medicine

  • CRISPR – the IP battle

  • Inside IP Spring Summer 2017

  • The Francis Crick Institute

  • Inside IP Autumn Winter 2016

  • Inside IP Spring Summer 2015

  • Inside IP Spring Summer 2014

  • Inside IP Spring Summer 2013